SCHEMBL3723909

SCHEMBL3723909

CCCCc1cccc(S(N)(=O)=O)c1S(N)(=O)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 9/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
BID P55957 3/20 0.39
MCL1 Q07820 3/20 0.39
BCL2L1 Q07817 2/20 0.39
BAK1 Q16611 2/20 0.39
KAT8 Q9H7Z6 2/20 0.39
PPARG P37231 1/20 0.39
PPARA Q07869 1/20 0.39
EP300 Q09472 1/20 0.39
KAT2A Q92830 1/20 0.39
KAT2B Q92831 1/20 0.39
KAT5 Q92993 1/20 0.39
SAE1 Q9UBE0 1/20 0.39
ELANE P08246 1/20 0.38
CTSG P08311 1/20 0.38
CA1 P00915 5/20 0.37
CA9 Q16790 4/20 0.37
CA12 O43570 3/20 0.37
CA7 P43166 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30140890 0.84 CA2 (0.49) CA2SMN1; SMN2CA1CA9CA12
SCHEMBL51728 0.84 CA2 (0.49) CA2SMN1; SMN2CA1CA9CA12
SCHEMBL18989503 0.83 CA2 (0.45) CA2SMN1; SMN2BIDMCL1BCL2L1
SCHEMBL3278456 0.83 CA2 (0.45) CA2SMN1; SMN2BIDMCL1BCL2L1
SCHEMBL6062879 0.83 CA2 (0.45) CA2SMN1; SMN2BIDMCL1BCL2L1
Ammonia Solution, Strong SCHEMBL28168503 0.83 CA2 (0.47) CA2SMN1; SMN2CA1CA9CA12
SCHEMBL7444688 0.83 CA2 (0.47) CA2SMN1; SMN2CA1CA9CA12
Methane SCHEMBL27933205 0.83 CA2 (0.47) CA2SMN1; SMN2CA1CA9CA12
SCHEMBL3978112 0.82 CA2 (0.44) CA2SMN1; SMN2BIDMCL1BCL2L1
SCHEMBL7261112 0.82 CA2 (0.44) CA2SMN1; SMN2BIDMCL1BCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010132016-A1 BIS-(SULFONYLAMINO) DERIVATIVES FOR TREATMENT OF PAIN AND INFLAMMATION ASTRAZENECA AB (SE) 2010-11-18 WO disclosed